Monday, October 17, 2016

The increase in the Pekao and ROM was not enough to pull the WIG20 at the pros – Onet.pl

WIG20 began the session from stage to 1.712,22 points, which was the lowest level in two weeks. Then most part of the session was in the black, but at the end of the day he went under the line and fell to 0.32 percent.

differently behaved the other indices – WIG lost 0.05%, mWIG 40 gained 0.73 per cent. and sWIG 80 decreased by 0.22 percent. Market turnover was about. 775 mln.

the fall of the prevail also on Western dancefloors – DAX lose 0.6 per cent. FTSE by 0.5%. while the CAC 0.3%.

the most among blue chips increased ROM (2.87 percent). and Pekao (0.79%). On Saturday, PZU said in a statement that together with the Polish Development Fund, is in talks to purchase from UniCredit group’s significant stake in Bank Pekao.

PGNiG said on Monday that he had received information about the LEGAL approval of a new gas tariff for PGNiG’s largest customers. It assumes an average growth in gas prices wysokometanowego 4 percent, and natural gas zaazotowanego 3.9 percent. The company’s shares rose by 0.19 percent.

Haitong Bank increased the recommendation for Asseco Poland sa to “buy” from “neutral” and target price to 60.5 rubles 60 rubles before. Analysts also podwyższyli target price for the Group kęty to 380,1 RUB with 305,2 rubles, while maintaining the recommendation to “neutral. The stock price Asseco declined by 0.93 per cent., a group of Kent has grown by 2.89 percent.

For a wide market, a strong decline of 4.64 percent. fixed YOU Games. The company announced on Monday that carries the date of the release of the game Sniper: Ghost Warrior 3 to 4 April 2017, whereas previously it was defined on January 27, 2017.

a Decline of 4.98 percent. said Alma, who said on Friday, after the session, filed in U.S. District Court in Krakow Declaration of bankruptcy with liquidation of property. Simultaneously, the company maintains previously filed a statement on opening procedures sanacyjnego.

Monday at the Warsaw parquet debuted Celon Pharma, which is a company biofarmaceutyczną involved in research, development, manufacture and sale of pharmaceutical products. The rate of CPC of the company grew by 19.04 per cent. at the seventh high turnover during the session (approx. 35 million rubles).

LikeTweet

No comments:

Post a Comment